IL13 and metabolic dysfunction-associated steatohepatitis: Furthermore, we demonstrate that not only is the IL13 pathway increased in patients with NASH, but also that oxidized LDL, commonly associated with inflammation in NASH, can induce the upregulation of IL13 transcript and protein in LECs.